Table 1

Baseline Characteristics

TAVR
(n = 145)
SAVR
(n = 135)
Age, yrs79.2 ± 4.979.0 ± 4.7
Male78/145 (53.8)71/135 (52.6)
NYHA functional classification
 I7/144 (4.9)3/134 (2.2)
 II67/144 (46.5)70/134 (52.2)
 III67/144 (46.5)57/134 (42.5)
 IV3/144 (2.1)4/134 (3.0)
STS-PROM score, %2.9 ± 1.63.1 ± 1.7
Logistic EuroSCORE, %8.4 ± 4.08.9 ± 5.5
Logistic EuroSCORE II, %1.9 ± 1.22.0 ± 1.3
Additive EuroSCORE, %7.4 ± 1.47.5 ± 1.4
Diabetes mellitus26/145 (17.9)28/135 (20.7)
Creatinine level >2 mg/dl2/145 (1.4)1/135 (0.7)
History of hypertension103/145 (71.0)103/135 (76.3)
Peripheral vascular disease6/145 (4.1)9/135(6.7)
Prior cerebrovascular accident24/145 (16.6)22/135 (16.3)
Chronic lung disease17/145 (11.7)16/135 (11.9)
 Cardiac risk factors
 Prior PCI11/145 (7.6)12/135 (8.9)
 Pre-existing pacemaker5/145 (3.4)6/135 (4.4)
 Prior MI8/145 (5.5)6/135 (4.4)
 Prior AF/atrial flutter40/144 (27.8)34/133 (25.6)

Values are mean ± SD or n/N (%).

AF = atrial fibrillation; EuroSCORE = European System for Cardiac Operative Risk Evaluation; MI = myocardial infarction; NYHA = New York Heart Association; PCI = percutaneous coronary intervention; SAVR = surgical aortic valve replacement; STS-PROM = Society of Thoracic Surgeons Predicted Risk Of Mortality; TAVR = transcatheter aortic valve replacement.

  • No statistical significant differences between groups were found for any variable.